다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

INVO

INVO BioScience (INVO)

INVO BioScience Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:INVO

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/10/24	22:00	GlobeNewswire Inc.	NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	NASDAQ:INVO	INVO BioScience Inc
2024/10/23	01:05	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:INVO	INVO BioScience Inc
2024/10/21	22:00	GlobeNewswire Inc.	INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences	NASDAQ:INVO	INVO BioScience Inc
2024/10/15	22:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/10/14	22:18	GlobeNewswire Inc.	INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)	NASDAQ:INVO	INVO BioScience Inc
2024/10/02	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/09/21	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/09/19	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/08/15	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/08/14	22:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INVO	INVO BioScience Inc
2024/08/14	22:00	GlobeNewswire Inc.	INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA	NASDAQ:INVO	INVO BioScience Inc
2024/05/22	05:39	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:INVO	INVO BioScience Inc
2024/05/16	05:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/05/16	05:15	GlobeNewswire Inc.	INVO Reports Record First Quarter 2024 Financial Results	NASDAQ:INVO	INVO BioScience Inc
2024/05/07	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/04/17	23:25	AllPennyStocks.com	Micro Cap Massively Bid Up Before Opening Bell	NASDAQ:INVO	INVO BioScience Inc
2024/04/17	05:59	GlobeNewswire Inc.	INVO Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:INVO	INVO BioScience Inc
2024/02/07	00:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INVO	INVO BioScience Inc
2024/02/01	23:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/01/23	22:00	GlobeNewswire Inc.	NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)	NASDAQ:INVO	INVO BioScience Inc
2024/01/17	22:00	GlobeNewswire Inc.	INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors	NASDAQ:INVO	INVO BioScience Inc
2024/01/17	07:29	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:INVO	INVO BioScience Inc
2024/01/11	06:46	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:INVO	INVO BioScience Inc
2024/01/11	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2024/01/04	07:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2023/12/29	07:04	Edgar (US Regulatory)	Form 424B7 - Prospectus [Rule 424(b)(7)]	NASDAQ:INVO	INVO BioScience Inc
2023/12/29	07:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2023/12/14	07:08	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INVO	INVO BioScience Inc
2023/12/14	06:53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
2023/12/11	22:00	PR Newswire (US)	NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal	NASDAQ:INVO	INVO BioScience Inc

검색 관련기사 보기:NASDAQ:INVO

1 2 3 4 5 6 7 8 9 다음 >>

US Dollar vs Sterling

Deutsche Telekom (QX)

Energy Select Sector SPDR

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관